The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis

Daclizumab is a monoclonal antibody that reduces inflammation in multiple sclerosis (MS). Through a retrospective analysis, our objective was to determine whether daclizumab treatment reduces the rate of brain structure atrophy in comparison to a mixture of other disease-modifying therapies (mainly...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Borges, Isabela T., Shea, Colin D., Ohayon, Joan, Jones, Blake C., Stone, Roger D., Ostuni, John, Shiee, Navid, McFarland, Henry, Bielekova, Bibiana, Reich, Daniel S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3619446/
https://ncbi.nlm.nih.gov/pubmed/23580931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2012.10.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados